Editorial on Cognitive deficits in schizophrenia and other neuropsychiatric disorders: Convergence of preclinical and clinical evidence

Editorial on Cognitive deficits in schizophrenia and other neuropsychiatric disorders: Convergence of preclinical and clinical evidence

Bibliographic Details
Main Authors:	Ales eStuchlik, Tomiki eSumiyoshi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-12-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	Cognition Animal Models clinical studies neuropsychiatric disorders preclinical studies
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnbeh.2014.00444/full

Similar Items

Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer’s Disease: Insights From Preclinical Models, Clinical Data, and Future Directions
by: Amalie Clement, et al.
Published: (2020-03-01)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
by: Kok Pin Ng, et al.
Published: (2021-03-01)

Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies
by: Ricardo Teixo, et al.
Published: (2022-08-01)

Aspects of animal models for major neuropsychiatric disorders
by: Lefter Radu, et al.
Published: (2014-01-01)

Habenula as a Neural Substrate for Aggressive Behavior
by: Flavia Venetucci Gouveia, et al.
Published: (2022-02-01)

Pharmaceutical Toxicology is the Most Important Component of Preclinical Studies
by: A. D. Durnev
Published: (2023-03-01)

Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update
by: Parina Asgharian, et al.
Published: (2022-09-01)

PRECLINICAL STUDY OF PHARMACOLOGICAL ACTIVITY OF ENTEROSORBENTE ON THE BASIS OF MONTMORILLONITE
by: Anton Tishin, et al.
Published: (2017-09-01)

Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
by: Natascha Ingrid Drude, et al.
Published: (2022-11-01)

Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies
by: Kainat Jamil, et al.
Published: (2024-03-01)

Reporting of 3Rs Approaches in Preclinical Animal Experimental Studies—A Nationwide Study
by: Birgitte S. Kousholt, et al.
Published: (2023-09-01)

Guidelines to Analyze Preclinical Studies Using Perinatal Derivatives
by: Ana Salomé Pires, et al.
Published: (2023-04-01)

Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence
by: Proshanta Roy, et al.
Published: (2021-05-01)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
by: Byron Creese, et al.
Published: (2022-01-01)

Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models
by: Ye-Piao Yan, et al.
Published: (2022-12-01)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
by: Sichen Ren, et al.
Published: (2021-09-01)

PICO entity extraction for preclinical animal literature
by: Qianying Wang, et al.
Published: (2022-09-01)

Early affective changes and increased connectivity in preclinical Alzheimer's disease
by: Carolyn A. Fredericks, et al.
Published: (2018-01-01)

Tandospirone, a 5-HT1A partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Towards the therapeutics of cognitive impairment of schizophrenia
by: Takashi eUehara, et al.
Published: (2014-09-01)

Dopamine transporter knockout rats as the new preclinical model of hyper- and hypo-dopaminergic disorders
by: I. Sukhanov, et al.
Published: (2019-12-01)

Preclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides—A Review
by: Ida-Johanne Jensen, et al.
Published: (2016-11-01)

Racotumomab: An Anti-Idiotype Vaccine Related to N-Glycolyl-Containing-Gangliosides. Preclinical and Clinical Data.
by: Ana María eVázquez, et al.
Published: (2012-10-01)

Irreproducibility –The deadly sin of preclinical research in drug development
by: Sadasivan Kalathil Pillai, et al.
Published: (2020-12-01)

Comparative evaluation of two suturing models for preclinical training
by: Triveni Kale, et al.
Published: (2019-01-01)

A Narrative Review of Preclinical In Vitro Studies Investigating microRNAs in Myocarditis
by: Olga Grodzka, et al.
Published: (2024-02-01)

Cannabidiol, cognition and schizophrenia: a narrative review
by: Trevor R. Norman
Published: (2024-02-01)

Neuropsychiatric complications of 500 cases of hyperthyroidism
by: Moetamedi M, et al.
Published: (1998-07-01)

Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy
by: Mary M. Ryan, et al.
Published: (2019-10-01)

Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
by: Dania Movia, et al.
Published: (2020-07-01)

Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
by: Marta Banchi, et al.
Published: (2022-10-01)

Using Zebrafish in Preclinical Drug Studies: Challenges and Opportunities
by: A. V. Kalueff, et al.
Published: (2023-09-01)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
by: Chiara Bastiancich, et al.
Published: (2021-01-01)

Letter to Editor: Neuropsychiatric Consequences of Deep Brain Stimulation in Patients with Chronic Movement Disorders
by: Seyed Kazem Malakouti, et al.
Published: (2016-07-01)

In-vivo evaluation of silk fibroin small-diameter vascular grafts: state of art of preclinical studies and animal models
by: Alberto Settembrini, et al.
Published: (2023-05-01)

Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis
by: Anzhu Wang, et al.
Published: (2022-04-01)

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
by: Raffaella Willmann, et al.
Published: (2020-02-01)

Engineered extracellular vesicles for ischemic stroke: a systematic review and meta-analysis of preclinical studies
by: Pengtao Li, et al.
Published: (2023-10-01)

Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
by: O. E. Klementyeva, et al.
Published: (2021-12-01)

Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
by: V. M. Kosman, et al.
Published: (2023-06-01)

The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia
by: Francesca Morganti, et al.
Published: (2018-09-01)